XML 370 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net loss $ (609,693) $ (209,275) $ (176,494)
Adjustments to reconcile net loss to net cash flow from operating activities:      
Stock-based compensation 73,968 78,130 120,893
Depreciation and amortization 18,595 12,493 10,421
(Accretion) Amortization of note premiums/discounts (3,244) (2,017) 2,910
Non-cash interest expense on liability related to the sale of future royalties 23,035 18,326 0
Non-cash interest expense on credit facility 9,317 0 0
Realized loss on investments 80 0 4,432
Changes in operating assets and liabilities:      
Accounts receivable 0 1,410 8,845
Prepaid expenses and other current assets (1,664) 11,603 (19,291)
Accounts payable (5,536) 32,998 (6,589)
Accrued expenses 32,117 (14,965) 17,750
Deferred revenue (866) (129,183) (112,501)
Operating lease, net 2,240 46,590 13,428
Other (1,200) 0 65
Net cash used in operating activities (462,851) (153,890) (136,131)
CASH FLOWS FROM INVESTING ACTIVITIES:      
Purchases of property, plant and equipment (141,469) (176,737) (52,777)
Purchases of investments (720,947) (246,141) (223,391)
Proceeds from sales and maturities of investments 442,344 326,723 270,751
Net cash used in investing activities (420,072) (96,155) (5,417)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from the issuance of common stock, net of offering costs 429,265 0 0
Proceeds from the sale of future royalties 50,000 250,000 0
Proceeds from credit facility 392,000 0 0
Payment of debt issuance costs (3,134) 0 0
Proceeds from the exercises of stock options 2,389 3,053 5,186
Proceeds from investment in joint venture 0 0 60,000
Net cash provided by financing activities 870,520 253,053 65,186
Net (decrease) increase in cash, cash equivalents and restricted cash (12,403) 3,008 (76,362)
Effect of exchange rate on cash, cash equivalents and restricted cash 4,197 (122) (67)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH:      
BEGINNING OF PERIOD 110,891 108,005 184,434
END OF PERIOD 102,685 110,891 108,005
Supplementary disclosure of cash flows:      
Income Taxes Paid (3,744) 0 (2)
Supplementary disclosure of non-cash investing activities:      
Capital expenditures included in accounts payable and accrued expenses 4,206 14,044 17,578
Supplementary disclosure of non-cash financing activities:      
Debt issuance costs included in accrued expenses $ 5,000 $ 0 $ 0